Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Fiber-Optic Microscope Helps Detect Cancer

By Labmedica International staff writers
Posted on 01 May 2014
Images: High-resolution fiber-optic endoscopic microscope reveals some of the same tissue features as conventional histology on a biopsied sample. Healthy oral mucosa: (a) endoscopic microscope; (b) conventional histology. Oral cancer: (c) endoscopic microscope; (d) conventional histology (Photo courtesy of the US National Institute of Health).
Images: High-resolution fiber-optic endoscopic microscope reveals some of the same tissue features as conventional histology on a biopsied sample. Healthy oral mucosa: (a) endoscopic microscope; (b) conventional histology. Oral cancer: (c) endoscopic microscope; (d) conventional histology (Photo courtesy of the US National Institute of Health).
An inexpensive, portable and reusable endoscopic microscope has been developed that will help clinicians detect and diagnose early-stage disease, primarily cancer.

An endoscopic microscope is a tool or technique that obtains histological images from inside the human body in real-time and some clinicians consider it as an optical biopsy.

An engineering scientist at the University of Arkansas (Fayetteville, AR, USA) has developed an inexpensive, endoscopic microscope capable of producing high-resolution, subcellular images of tissue in real time. The fiber-optic device, which is portable, reusable and easily packaged with conventional endoscopes, will help clinicians detect and diagnose early-stage disease, primarily cancer.

The system, developed also serves as an intraoperative monitoring device by providing a preview biopsy that is, helping clinicians target ideal locations on lesions prior to and during surgical biopsies and by capturing high-resolution images of tumor margins in real time. The latter will help surgeons know whether they have totally removed a tumor. The microscope is built from a single fiber optic bundle that includes thousands of flexible, small-caliber fibers. This bundle is roughly one millimeter in diameter and could be inserted into the biopsy channel of a standard endoscope.

The system requires a topical contrast agent to facilitate fluorescent imaging. It can produce images at sub-cellular resolution, which allows clinicians to see the early stages of cell deformations that could lead to precancerous conditions. The probe can be sterilized and reused. The entire system, which fits into a conventional-sized briefcase, costs approximately USD 2,500.

A prototype of the system has been tested at the M.D. Anderson Cancer Center (Houston, TX, USA). Studies there focused on various conditions leading to esophageal cancer. The work provided high-resolution images of cell structure and morphology, specifically nuclear-to-cytoplasmic ratio, a critical indicator of cell behavior leading up to a precancerous condition. Results obtained from the endoscopic microscope were confirmed by standard histopathological examination of biopsied tissue.

Timothy Muldoon, MD, PhD, an assistant professor of biomedical engineering who developed the endoscopic microscope, said, “My dream is to disseminate this technology to a broad scope of medical facilities, hospitals and various clinics, of course, but also to take it into underserved and rural, even remote, areas. Its compactness and portability will allow us to do this.”

Related Links:

University of Arkansas
M.D. Anderson Cancer Center 



DIASYS DIAGNOSTIC SYSTEMS
KARL HECHT GMBH & CO KG
77 ELEKTRONIKA

Channels

Genetic Tests

view channel

Padlock Probe Assay Rapidly Detects Cardiac Disease Gene Mutations

A recent paper described a novel next generation sequencing (NGS) assay for detecting cardiac disease gene mutations with improved accuracy, flexibility, turnaround time, and cost. By using double-stranded DNA probes (complementary long "padlock" probes or cLPPs), investigators at Stanford University (Palo Alto, CA,... Read more

Hematology

view channel
Image: Immunochemistry of bone marrow biopsy from an acute myeloid leukemia patient showing sheets of CD34 positive cells; corresponding bone marrow aspirate showed only 20% blasts (Photo courtesy of All India Institute of Medical Sciences).

Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.... Read more

Industry News

view channel

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. The liquid biopsy test is based on bladder cancer DNA methylation biomarkers developed... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.